Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-18
1999-02-16
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514259, 514260, A61K 31505
Patent
active
058721231
ABSTRACT:
A method for alleviating chronic fatigue syndrome with the administration of antiviral agents. Based on clinical tests, chronic fatigue syndrome is a persistent herpes virus infection and thus administration of antiviral agents are shown to alleviate the symptoms associated with the disorder. Based on therapeutic trials, patients receiving the recommended antiviral treatment, have experienced significant reduction or elimination of the symptoms associated with chronic fatigue syndrome. A method of diagnosis of the chronic fatigue syndrome is further disclosed.
REFERENCES:
patent: 4544634 (1985-10-01), Krenitsky
patent: 4695570 (1987-09-01), Krenitsky
patent: 4897394 (1990-01-01), Zimmerman et al.
patent: 4957924 (1990-09-01), Beauchamp
patent: 5055296 (1991-10-01), Wagle et al.
patent: 5061708 (1991-10-01), Krenitsky
patent: 5079252 (1992-01-01), Beauchamp
patent: 5189022 (1993-02-01), Bridge et al.
patent: 5206008 (1993-04-01), Loria
patent: 5213106 (1993-05-01), Lerner
patent: 5267570 (1993-12-01), Preston
patent: 5312817 (1994-05-01), Snorrason
patent: 5357968 (1994-10-01), Lerner
patent: 5405850 (1995-04-01), Blumenkopf
patent: 5426020 (1995-06-01), Levy et al.
patent: 5461042 (1995-10-01), Loria
patent: 5464020 (1995-11-01), Lerner
patent: 5491150 (1996-02-01), Aoki et al.
patent: 5538856 (1996-07-01), Levy et al.
patent: 5545550 (1996-08-01), Grossberg et al.
patent: 5545670 (1996-08-01), Bissbort et al.
Straues et al, 1988 New Eng J of Med Dec. 29, 1988, 319(26) pp. 1692-1698.
"The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study", Keiji Fukuda, M.D., et al Annals of Internal Medicine, vol. 121, No. 12, pp. 953-959.
"Lack of Evidence for Infection with Known Human and Animal Retroviruses in Patients with Chronic Fatigue Syndrome", Clin. Infec. Disease 18, Suppl. 1, 1994, pp. S121-S125.
"Long-Term Serological Follow-Up of Patients for Epstein-Barr Virus After Recovery from Infectious Mononucleosis", The Journal of Infectious Diseases, S. Horwitz, vol. 151, No. 5, Jun., 1985, pp. 1150-1153.
"Studies on Enterovirus in Patients with Chronic Fatigue Syndrome", J.W. Gow, et al Clinical Infectious Diseases, 1994; 18 (Suppl. 1), pp. S126-S129.
"Molecular Biology and Immunology of Cytomegalovirus", Paul D. Griffiths and Jane E. Grundy, Biochem. J., (1987) vol. 241, pp. 313-324.
"Herpes Simplex Encephalitis-Vidarabine Therapy and Diagnositc Problems", Richard J. Whitley, et al; The New England Journal of Medicine, Feb. 5, 1981; vol. 304, No. 6, pp. 313-318.
"In Situ Detection of Human Cytomegalovirus Immediately-Early Gene Transcripts, etc." Tzyy-Choou Wu, et al, AIDS, 1992, vol. 6, No. 8, pp. 777-785.
"Cytomegalovirus as a Possible Cause of a Disease Resembling Infectious Mononucleosis" E. Klemola and L. Kaariainen, British Medical Journal, 1995, vol. 2, pp. 1099-1102.
"Infectious Mononucleosis", James C. Niederman, et al, Journal of the American Medical Association, 1968, vol. 203, No. 3, pp. 205-209.
"Medical Consequences of Persistent Viral Infection", Peter Southern and Michael B.A. Oldstone, New England Journal of Medicine, vol. 314, No. 6, pp. 359-367.
"Lack of Evidence for Infection with Known Human and Animal Retroviruses in Patients with Chronic Fatigue Syndrome", Walid Heneine, et al, Clinical Infectious Diseases 1994; 18 (Suppl. 1), pp. S121-S125.
"Repetitively Negative Changing T Waves at 24-h Electrocardiographic Monitors in Patients with the Chronic Fatigue Syndrome", A. Martin Lerner, et al; Chest vol. 104, No. 5, Nov. 1993, pp. 1417-1421.
"Abnormal Left Ventricular Myocardial Dynamics in Eleven Patients with Chronic Fatigue Syndrome", Clinical Nuclear Medicine, Aug. 1994, vol. 19, No. 8, pp. 675-677.
"Immune Surveillance Against Epstein-Barr Virus", Denis J. Moss, et al, Immunology, vol. 4, 1992, pp. 97-104.
"A Second Site for Epstein-Barr Virus Shedding: The Uterine Cervix", John W. Sixbey, et al, The Lancet, Nov. 1986, pp. 1122-1124.
"Prolonged Inhibitory Effect of 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine Against Replication of Epstein-Barr Virus", Jung-Chung Lin, et al, Journal of Virology, Apr., 1984, vol. 50, No. 1, pp. 50-55.
"Epstein-Barr Virus Replication in Oropharyngeal Epithelial Cells", John W. Sixbey, et al, The New England Journal of Medicine, vol. 310, No. 19, 1984, pp. 1225-1230.
"Chronic Epstein-Barr Virus Infection Associated with Fever and Interstitial Pneumonitis", Robert T. Schooley, et al, Annals of Internal Medicine, 1986, vol. 104, pp. 636-643.
"Long-Term Serological Follow-Up of Patients for Epstein-Barr Virus After Recovery from Infectious Mononucleosis", Charles A. Horowitz, et al, The Journal of Infectious Diseases, vol. 151, No. 6, Jun. 1985, pp. 1150-1153.
"Is Neurally Mediated Hypotension an Unrecognised Cause of Chronic Fatigue?", Peter C. Rowe, et al, The Lancet, vol. 345, pp. 623-624.
"Chronic Fatigue Syndrome", Principles and Practice of Infectious Diseases--4th Ed., R. T. Schooley, 1995, pp. 1306-1310.
"Acyclovir Treatment of the Chronic Fatigue Syndrome", Stephen E. Straus, et al, The New England Journal of Medicine, vol. 319, No. 26, pp. 1692-1698.
"The Chronic Fatigue Syndrome--One Entity or Many?", Morton N. Swartz, The New England Journal of Medicine, vol. 319, No. 26, 1988, pp. 1726-1728.
"The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome", Issam Bou-Holaigah, et al, Journal of the American Medical Association, vol. 274, No. 12, pp. 961-967.
"A Cluster of Patients with a Chronic Mononucleosis-Like Syndrome: Is Epstein-Barr Virus the Cause?", G.P. Holmes, et al, Journal of the American Medical Association, 1987, vol. 257, No. 17, pp. 2297-2302.
"Frequency of `Chronic Active Epstein-Barr Virus Infection` in a General Medical Practive", Dedra Buchwald, et al, Journal of the American Medical Association, 1987, vol. 257, No. 17, pp. 2303-2307.
"The Epstein-Barr Virus: Host Balance in Acute Infectious Mononucleosis Patients Receiving Acyclovir Anti-Viral Therapy", Q.Y. Yao, Int. J. Cancer, 1989, vol. 43, pp. 61-66.
"A Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin Therapy in Patients with Chronic Fatigue Syndrome", Andrew Lloyd, et al, The American Journal of Medicine,1990, vol. 89, pp. 561-568.
"A Controlled Trial of Intravenous Immunoglobulin G in Chronic Fatigue Syndrome" P.K. Peterson, et al, The American Journal of Medicine, 1990, vol. 89, pp. 554-560.
"Chronic Fatigue Syndrome: A Working Case Definition", G.P. Holmes, et al Annals of Internal Medicine, 1988, vol. 108, pp. 387-389.
"Leukocyte-Transforming Agent: Prolonged Excretion by Patients with Mononucleosis and Excretion by Normal Individuals", H. Dean Golden, et al, The Journal of Infectious Diseases, 1973, vol. 127, No. 4, pp. 471-473.
"Enhanced Serological and Virological Findings of Epstein-Barr Virus in Patients with AIDS and AIDS-Related Complex", Ciro V. Sumaya, et al, The Journal of Infectious Diseases, 1986, vol. 154, No. 5, pp. 864-870.
"Chest Pain and Palpitation", Eugene Braunwald, Harrison's Principles of Internal Medicine (10th Ed.), (1983) pp. 25-31.
"Chronic Fatigue Syndrome--Information for Physicians", National Institue of Allergy and Infectious Diseases, National Institutes of Health, Sep., 1996, pp. 1-16.
"Human Herpes Virus-6: Clinical Implications of a Recently Discovered Ubiquitous Agent", Charles T. Leach, The Journal of Pediatrics, 1992, vol. 121, No. 2, pp. 173-181.
"Summary: Viral Studies of Chronic Fatigue Syndrome", Dharam V. Ablashi, Clinical Infectious Diseases, 1994:18 (Suppl. 1), pp. S130-S133.
"Epstein-Barr Virus-Specific IgA Serum Antibodies as an Outstanding Feature of Nasopharyngeal Carcinoma", Gertrude Henle, et al, Int. J. Cancer, 1976, vol. 17, pp. 1-7.
"Viral Latency and Transformation: The Strategy of Epstein-Barr Virus", George Klein, Cell, 1989, vol. 58, pp. 5-8.
"IgM Antibodies Specific for Epstein-Barr Virus in Infectious Mononucleosis Without Heterophil Antibodies", J. Nikoskelainen, et al, British Medical Journal, 1974, vol. 4, pp. 72-75.
"Repression of Human Cytomegalovirus Major Immediate Early Gene Expression in a Monocytic Cell
LandOfFree
Method for diagnosing and alleviating the symptoms of chronic fa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing and alleviating the symptoms of chronic fa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing and alleviating the symptoms of chronic fa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062699